Nordicus Partners NORD
OTC NORD
$4.02 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nordicus Partners (NORD) Net Equity Issued and Repurchased (2011 - 2026)

Updated

Nordicus Partners' Net Equity Issued and Repurchased came in at $123,750 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 69.8% from $409,970 a year earlier and down 72.3% from the prior quarter.

Analysis

Nordicus Partners (NORD) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Nordicus Partners reported Net Equity Issued and Repurchased of $4.07 million, up 228.2% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $4.35 million, up 389.5% from FY2025.

  • Net Equity Issued and Repurchased has increased in each of the last three fiscal years, with a four-year compound annual growth rate of 81.6% (FY2022 to FY2026).
  • Going back by fiscal year, Net Equity Issued and Repurchased was $889,477 in FY2025 (+190.7%), $306,000 in FY2024 (+166.1%), $115,000 in FY2023 (-71.3%) and $400,000 in FY2022.
  • The fiscal Q1 2027 figure represents the lowest quarterly Net Equity Issued and Repurchased since fiscal Q1 2025.
  • Year-over-year, Net Equity Issued and Repurchased increased in seven of the last eight quarters, with growth averaging 309.3%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in fiscal Q2 2026 (growth of 935.7%), and the weakest in fiscal Q1 2027 (a decline of 69.8%).
  • Business Quant data shows NORD's Net Equity Issued and Repurchased at $446,876 (Q4 2026), $1.49 million (Q3 2026) and $2.01 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -9.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -346.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Nordicus Partners 78.16 Mn 77.63 Mn - 123,750.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 123,750.00
Mar 31, 2026 446,876.00
Dec 31, 2025 1.49 Mn
Sep 30, 2025 2.01 Mn
Jun 30, 2025 409,970.00
Mar 31, 2025 313,477.00
Dec 31, 2024 128,670.00
Sep 30, 2024 387,330.00
Jun 30, 2024 60,000.00
Mar 31, 2024 126,000.00
Dec 31, 2023 75,000.00
Sep 30, 2023 80,000.00
Jun 30, 2023 25,000.00
Mar 31, 2022 200,000.00
Mar 31, 2020 -1,000.00
Mar 31, 2012 -1,000.00
Mar 31, 2011 8,000.00
API Access

Nordicus Partners Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NORD&period=max&api_key=YOUR_API_KEY